Total Number of Communication Reports: 0
Monthly communication reports in the last 6 months: 0
| Subject matters | Details | Categories |
|---|---|---|
|
Health, Industry, Science and Technology
|
Organon Canada’s objective is to preserve a regulatory framework which creates a favourable business environment for the development of the life science sector, including biosimilar drugs and women’s health products, which are the company’s main sectors of activities.
|
Legislative Proposal, Bill or Resolution
|
|
Health, Industry, Science and Technology
|
Representations relating to the conditions under which biosimilar drugs are marketed and reimbursed in Canada. More specifically, representations are made to support a favorable and knowledgeable environment to implement new or improve current women’s health programs, the integration of biosimilar drugs into the drug plans administered by the Federal Government and to emphasize the importance that the federal government respect their respective jurisdiction with respect to the approval, marketing and reimbursement of drugs.
|
Policies or Program
|
|
Health
|
To actively promote the enhancement of publicly funded women’s health initiatives/programs.
|
Policies or Program
|
|
Health, Industry, Science and Technology
|
To actively promote the value of the pharmaceutical industry for Canada's economic health and well being, but more importantly for the health and well being of its citizens and to propose solutions for integrated health care in Canada.
|
Policies or Program
|
|
Health, Industry, Science and Technology
|
To recommend policies that will attract increased investment in the pharmaceutical and well being industry, such as on policies, research programs and policies and the Innovation Agenda.
|
Policies or Program
|
Address:
16766 Transcanadienne, Canada
Kirkland, QC H9H 4M7
Canada
Telephone number:
800-387-1326
Web address:
https://www.organon.com/canada-fr/
Geneviève Gauthier, Directrice associée, politique santé & accès
Organon Canada Inc. / Organon Canada Inc. is not a coalition.
The activities of Organon Canada Inc. / Organon Canada Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Organon Canada Inc. / Organon Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Jean Philippe Fournier | Public offices held
Firm: Teneo